fbpx

Réglementation

Medicine shouldn’t just be cheap; it should be accessible

The new guidelines the Patented Medicine Prices Review Board will use to determine whether the price of a new medication is acceptable or too high are so unclear that both pharmaceutical companies and patients’ rights groups are united in their criticism of them.

Back to top